{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:14:16Z","timestamp":1794662056069,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-68129-x","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:24:07Z","timestamp":1768955047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preventing premature deaths through polygenic risk scores"],"prefix":"10.1038","volume":"17","author":[{"given":"Melisa","family":"Chuong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4593-1186","authenticated-orcid":false,"given":"Michael E.","family":"Weale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Riveros-Mckay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-8133","authenticated-orcid":false,"given":"Nilesh J.","family":"Samani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Plagnol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"McVean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9418-9577","authenticated-orcid":false,"given":"Euan A.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamus","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-2546","authenticated-orcid":false,"given":"Jack W.","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"68129_CR1","unstructured":"Centers for Disease Control and Prevention. Fast Facts: Health and Economic Costs of Chronic Conditions. https:\/\/www.cdc.gov\/chronic-disease\/data-research\/facts-stats\/index.html (accessed 15 Aug 2024)."},{"key":"68129_CR2","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMoa1600249","volume":"375","author":"HG Welch","year":"2016","unstructured":"Welch, H. G., Prorok, P. C., O\u2019Malley, A. J. & Kramer, B. S. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. N. Engl. J. Med. 375, 1438\u20131447 (2016).","journal-title":"N. Engl. J. Med."},{"key":"68129_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2147\/VHRM.S250735","volume":"16","author":"ST Saw","year":"2020","unstructured":"Saw, S. T., Leong, B. D. K. & Aziz, D. A. A. Early Detection of Undiagnosed Abdominal Aortic Aneurysm and Sub-Aneurysmal Aortic Dilatations in Patients with High-Risk Coronary Artery Disease: The Value of Targetted Screening Programme. Vasc. Health Risk Manag. 16, 215\u2013229 (2020).","journal-title":"Vasc. Health Risk Manag."},{"key":"68129_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamaoncol.2019.3876","volume":"6","author":"T Mukama","year":"2020","unstructured":"Mukama, T. et al. Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer. JAMA Oncol. 6, 68\u201374 (2020).","journal-title":"JAMA Oncol."},{"key":"68129_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","volume":"53","author":"SA Lambert","year":"2021","unstructured":"Lambert, S. A. et al. The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation. Nat. Genet. 53, 420\u2013425 (2021).","journal-title":"Nat. Genet."},{"key":"68129_CR6","doi-asserted-by":"publisher","first-page":"e0307270","DOI":"10.1371\/journal.pone.0307270","volume":"19","author":"DJ Thompson","year":"2024","unstructured":"Thompson, D. J. et al. A systematic evaluation of the performance and properties of the UK Biobank Polygenic Risk Score (PRS) Release. PLOS ONE 19, e0307270 (2024).","journal-title":"PLOS ONE"},{"key":"68129_CR7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219\u20131224 (2018).","journal-title":"Nat. Genet."},{"key":"68129_CR8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S1470-2045(20)30398-3","volume":"21","author":"SW Duffy","year":"2020","unstructured":"Duffy, S. W. et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Lancet Oncol. 21, 1165\u20131172 (2020).","journal-title":"Lancet Oncol."},{"key":"68129_CR9","doi-asserted-by":"crossref","unstructured":"Maxwell, K. N., Domchek, S. M., Nathanson, K. L. & Robson, M. E. Population Frequency of Germline BRCA1\/2 Mutations. J. Clin. Oncol. 34, 4183\u20134185 (2016).","DOI":"10.1200\/JCO.2016.67.0554"},{"key":"68129_CR10","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","volume":"75","author":"SO Beheshti","year":"2020","unstructured":"Beheshti, S. O., Madsen, C. M., Varbo, A. & Nordestgaard, B. G. Worldwide Prevalence of Familial Hypercholesterolemia. JACC 75, 2553\u20132566 (2020).","journal-title":"JACC"},{"key":"68129_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","volume":"26","author":"N Mars","year":"2020","unstructured":"Mars, N. et al. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers. Nat. Med. 26, 549\u2013557 (2020).","journal-title":"Nat. Med."},{"key":"68129_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48938-2","volume":"15","author":"B Jermy","year":"2024","unstructured":"Jermy, B. et al. A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk. Nat. Commun. 15, 5007 (2024).","journal-title":"Nat. Commun."},{"key":"68129_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.amjcard.2021.02.032","volume":"148","author":"ME Weale","year":"2021","unstructured":"Weale, M. E. et al. Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and Ancestries. Am. J. Cardiol. 148, 157\u2013164 (2021).","journal-title":"Am. J. Cardiol."},{"key":"68129_CR14","doi-asserted-by":"publisher","first-page":"e003304","DOI":"10.1161\/CIRCGEN.120.003304","volume":"14","author":"F Riveros-Mckay","year":"2021","unstructured":"Riveros-Mckay, F. et al. Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction. Circ. Genom. Precis. Med. 14, e003304 (2021).","journal-title":"Circ. Genom. Precis. Med."},{"key":"68129_CR15","doi-asserted-by":"publisher","first-page":"e2339670","DOI":"10.1001\/jamanetworkopen.2023.39670","volume":"6","author":"X Chen","year":"2023","unstructured":"Chen, X., Heisser, T., Cardoso, R., Hoffmeister, M. & Brenner, H. Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk. JAMA Netw. Open 6, e2339670 (2023).","journal-title":"JAMA Netw. Open"},{"key":"68129_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41416-023-02536-z","volume":"130","author":"M Tamlander","year":"2024","unstructured":"Tamlander, M. et al. Genome-wide polygenic risk scores for colorectal cancer have implications for risk-based screening. Br. J. Cancer 130, 651\u2013659 (2024).","journal-title":"Br. J. Cancer"},{"key":"68129_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22637-8","volume":"12","author":"E Widen","year":"2022","unstructured":"Widen, E., Lello, L., Raben, T. G., Tellier, L. C. A. M. & Hsu, S. D. H. Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk Reduction. Sci. Rep. 12, 18173 (2022).","journal-title":"Sci. Rep."},{"key":"68129_CR18","doi-asserted-by":"publisher","first-page":"100118","DOI":"10.1016\/j.xgen.2022.100118","volume":"2","author":"N Mars","year":"2022","unstructured":"Mars, N. et al. Genome-wide risk prediction of common diseases across ancestries in one million people. Cell Genomics 2, 100118 (2022).","journal-title":"Cell Genomics"},{"key":"68129_CR19","doi-asserted-by":"publisher","first-page":"100241","DOI":"10.1016\/j.xgen.2022.100241","volume":"3","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Global Biobank analyses provide lessons for developing polygenic risk scores across diverse cohorts. Cell Genomics 3, 100241 (2023).","journal-title":"Cell Genomics"},{"key":"68129_CR20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry, A. et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am. J. Epidemiol. 186, 1026\u20131034 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"68129_CR21","doi-asserted-by":"publisher","first-page":"e1009723","DOI":"10.1371\/journal.pgen.1009723","volume":"17","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Holmes, C. & McVean, G. The impact of age on genetic risk for common diseases. PLOS Genet 17, e1009723 (2021).","journal-title":"PLOS Genet"},{"key":"68129_CR22","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/cpt.2715","volume":"112","author":"A Oni-Orisan","year":"2022","unstructured":"Oni-Orisan, A. et al. Polygenic Risk Score and Statin Relative Risk Reduction for Primary Prevention of Myocardial Infarction in a Real-World Population. Clin. Pharmacol. Ther. 112, 1070\u20131078 (2022).","journal-title":"Clin. Pharmacol. Ther."},{"key":"68129_CR23","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/eurheartj\/ehae649","volume":"46","author":"H Schunkert","year":"2025","unstructured":"Schunkert, H. et al. Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology. Eur. Heart J. 46, 1372\u20131383 (2025).","journal-title":"Eur. Heart J."},{"key":"68129_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurjpc\/zwae004","volume":"31","author":"A Fuat","year":"2024","unstructured":"Fuat, A. et al. A polygenic risk score added to a QRISK\u00ae2 cardiovascular disease risk calculator demonstrated robust clinical acceptance and clinical utility in the primary care setting. Eur. J. Prev. Cardiol. 31, 716\u2013722 (2024).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"68129_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/jpm13040573","volume":"13","author":"JK Park","year":"2023","unstructured":"Park, J. K. & Lu, C. Y. Polygenic Scores in the Direct-to-Consumer Setting: Challenges and Opportunities for a New Era in Consumer Genetic Testing. J. Pers. Med. 13, 573 (2023).","journal-title":"J. Pers. Med."},{"key":"68129_CR26","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).","journal-title":"PLoS Med."},{"key":"68129_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"68129_CR28","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","volume":"28","author":"L Hao","year":"2022","unstructured":"Hao, L. et al. Development of a clinical polygenic risk score assay and reporting workflow. Nat. Med. 28, 1006\u20131013 (2022).","journal-title":"Nat. Med."},{"key":"68129_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17374-3","volume":"11","author":"AC Fahed","year":"2020","unstructured":"Fahed, A. C. et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat. Commun. 11, 3635 (2020).","journal-title":"Nat. Commun."},{"key":"68129_CR30","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang, J. & Yu, K. F. What\u2019s the Relative Risk? A Method of Correcting the Odds Ratio in Cohort Studies of Common Outcomes. JAMA 280, 1690\u20131691 (1998).","journal-title":"JAMA"},{"key":"68129_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ng853","volume":"31","author":"PDP Pharoah","year":"2002","unstructured":"Pharoah, P. D. P. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31, 33\u201336 (2002).","journal-title":"Nat. Genet."},{"key":"68129_CR32","first-page":"414","volume":"38","author":"HR THOMPSON","year":"1951","unstructured":"Thompson, H. R. Truncated lognormal distributions: I. Solution by moments. Biometrika 38, 414\u2013422 (1951).","journal-title":"Biometrika"},{"key":"68129_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00001648-199305000-00006","volume":"4","author":"H Brenner","year":"1993","unstructured":"Brenner, H., Gefeller, O. & Greenland, S. Risk and rate advancement periods as measures of exposure impact on the occurrence of chronic diseases. Epidemiology 4, 229 (1993).","journal-title":"Epidemiology"},{"key":"68129_CR34","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail, M. H. et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl. Cancer Inst. 81, 1879\u20131886 (1989).","journal-title":"J. Natl. Cancer Inst."},{"key":"68129_CR35","doi-asserted-by":"publisher","unstructured":"Thompson, D. & Chuong, M. genomics-dev\/clinical_benefits: 1.0.0 software for \u2018Preventing premature deaths through polygenic risk scores\u2019. https:\/\/doi.org\/10.5281\/zenodo.17877984 (accessed 11 Dec 2025).","DOI":"10.5281\/zenodo.17877984"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68129-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:59:58Z","timestamp":1770296398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68129-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68129"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-68129-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.C., D.T., M.E.W., F.R-M., D.W., V.P., G.M., P.D., and S.H. are current or former employees of Genomics Ltd, and own or have owned shares or stock options in the company. G.M. and P.D. are also partners in Peptide Groove LLP. E.A.A. reports advisory board fees from SequenceBio, Foresite Labs, Pacific Biosciences, and Versant Ventures. E.A.A. has ownership interest in Personalis, Deepcell, Svexa, Candela, Parameter Health, Saturnus Bio, outside the submitted work. E.A.A. is a non-executive director of AstraZeneca and Svexa. E.A.A. receives collaborative research support from Illumina, Pacific Biosciences, Oxford Nanopore, Cache, Cellsonics, outside the submitted work. JWO\u2019S is supported by the AHA Postdoctoral fellowship and ACC postdoctoral fellowship and has had consultancy relationships with Google AI, Google Deepmind and Foresite Labs (outside the current work).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1379"}}